128 related articles for article (PubMed ID: 7849068)
1. Fluorescent derivatives of diphenyl [1-(N-peptidylamino)alkyl]phosphonate esters: synthesis and use in the inhibition and cellular localization of serine proteases.
Abuelyaman AS; Hudig D; Woodard SL; Powers JC
Bioconjug Chem; 1994; 5(5):400-5. PubMed ID: 7849068
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and kinetic studies of diphenyl 1-(N-peptidylamino)alkanephosphonate esters and their biotinylated derivatives as inhibitors of serine proteases and probes for lymphocyte granzymes.
Abuelyaman AS; Jackson DS; Hudig D; Woodard SL; Powers JC
Arch Biochem Biophys; 1997 Aug; 344(2):271-80. PubMed ID: 9264539
[TBL] [Abstract][Full Text] [Related]
3. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters.
Oleksyszyn J; Powers JC
Biochemistry; 1991 Jan; 30(2):485-93. PubMed ID: 1988040
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase.
Jackson DS; Fraser SA; Ni LM; Kam CM; Winkler U; Johnson DA; Froelich CJ; Hudig D; Powers JC
J Med Chem; 1998 Jun; 41(13):2289-301. PubMed ID: 9632362
[TBL] [Abstract][Full Text] [Related]
5. alpha-Aminoalkylphosphonate di(chlorophenyl) esters as inhibitors of serine proteases.
Boduszek B; Brown AD; Powers JC
J Enzyme Inhib; 1994; 8(3):147-58. PubMed ID: 7539484
[TBL] [Abstract][Full Text] [Related]
6. Irreversible inhibition of serine proteases by peptidyl derivatives of alpha-aminoalkylphosphonate diphenyl esters.
Oleksyszyn J; Powers JC
Biochem Biophys Res Commun; 1989 May; 161(1):143-9. PubMed ID: 2730652
[TBL] [Abstract][Full Text] [Related]
7. Novel amidine-containing peptidyl phosphonates as irreversible inhibitors for blood coagulation and related serine proteases.
Oleksyszyn J; Boduszek B; Kam CM; Powers JC
J Med Chem; 1994 Jan; 37(2):226-31. PubMed ID: 8295209
[TBL] [Abstract][Full Text] [Related]
8. Biotinylated isocoumarins, new inhibitors and reagents for detection, localization, and isolation of serine proteases.
Kam CM; Abuelyaman AS; Li Z; Hudig D; Powers JC
Bioconjug Chem; 1993; 4(6):560-7. PubMed ID: 8305526
[TBL] [Abstract][Full Text] [Related]
9. Dipeptide phosphonates as inhibitors of dipeptidyl peptidase IV.
Boduszek B; Oleksyszyn J; Kam CM; Selzler J; Smith RE; Powers JC
J Med Chem; 1994 Nov; 37(23):3969-76. PubMed ID: 7966157
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and kinetic studies of an amidine-containing phosphonofluoridate: a novel potent inhibitor of trypsin-like enzymes.
Ni LM; Powers JC
Bioorg Med Chem; 1998 Oct; 6(10):1767-73. PubMed ID: 9839006
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric preference of serine proteases toward phosphonate and phosphinate esters.
Walker B; Wharry S; Hamilton RJ; Martin SL; Healy A; Walker BJ
Biochem Biophys Res Commun; 2000 Oct; 276(3):1235-9. PubMed ID: 11027616
[TBL] [Abstract][Full Text] [Related]
12. Active site mapping of the serine proteases human leukocyte elastase, cathepsin G, porcine pancreatic elastase, rat mast cell proteases I and II. Bovine chymotrypsin A alpha, and Staphylococcus aureus protease V-8 using tripeptide thiobenzyl ester substrates.
Harper JW; Cook RR; Roberts CJ; McLaughlin BJ; Powers JC
Biochemistry; 1984 Jun; 23(13):2995-3002. PubMed ID: 6380580
[TBL] [Abstract][Full Text] [Related]
13. Chymase-directed serine protease inhibitor that reacts with a single 30-kDa granzyme and blocks NK-mediated cytotoxicity.
Woodard SL; Jackson DS; Abuelyaman AS; Powers JC; Winkler U; Hudig D
J Immunol; 1994 Dec; 153(11):5016-25. PubMed ID: 7963562
[TBL] [Abstract][Full Text] [Related]
14. Site-selective chemical modification of chymotrypsin using peptidyl derivatives bearing optically active diphenyl 1-amino-2-phenylethylphosphonate: Stereochemical effect of the diphenyl phosphonate moiety.
Ono S; Nakai T; Kuroda H; Miyatake R; Horino Y; Abe H; Umezaki M; Oyama H
Biopolymers; 2016 Nov; 106(4):521-30. PubMed ID: 26615968
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity studies of fluoroketone inhibitors of alpha-lytic protease and human leukocyte elastase.
Govardhan CP; Abeles RH
Arch Biochem Biophys; 1990 Jul; 280(1):137-46. PubMed ID: 2353815
[TBL] [Abstract][Full Text] [Related]
16. Peptidic phosphonylating agents as irreversible inhibitors of serine proteases and models of the tetrahedral intermediates.
Sampson NS; Bartlett PA
Biochemistry; 1991 Feb; 30(8):2255-63. PubMed ID: 1998684
[TBL] [Abstract][Full Text] [Related]
17. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites.
Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E
Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453
[TBL] [Abstract][Full Text] [Related]
18. Sulfonyl fluoride serine protease inhibitors inactivate RNK-16 lymphocyte granule proteases and reduce lysis by granule extracts and perforin.
Ewoldt GR; Winkler U; Powers JC; Hudig D
Mol Immunol; 1992 Jun; 29(6):713-21. PubMed ID: 1603092
[TBL] [Abstract][Full Text] [Related]
19. Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins.
Odake S; Kam CM; Narasimhan L; Poe M; Blake JT; Krahenbuhl O; Tschopp J; Powers JC
Biochemistry; 1991 Feb; 30(8):2217-27. PubMed ID: 1998680
[TBL] [Abstract][Full Text] [Related]
20. Novel diphenyl esters of peptidyl alpha-aminoalkylphosphonates as inhibitors of chymotrypsin and subtilisin.
Pietrusewicz E; Sieńczyk M; Oleksyszyn J
J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1229-36. PubMed ID: 19912056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
